Form 4: Avita Medical Director Cary Guy Vance Acquires Shares and Stock Options

Director Cary Guy Vance of Avita Medical, Inc. reports acquisition of shares and stock options.

Summary

• On June 5, 2024, Cary Guy Vance, a director of Avita Medical, Inc., acquired 9,200 shares of common stock and 3,943 stock options.
• The shares were acquired through an award of Restricted Stock Units (RSUs) that vest 12 months following the grant date.
• The stock options have an exercise price of $9.51, are exercisable from June 5, 2025, and expire on June 5, 2034.
• Following the transaction, Vance directly owns 25,749 shares of common stock, including unvested RSUs, and 3,943 stock options.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock and option awards to a director. The acquisition of shares and options by a director is generally viewed as a positive signal, but without additional context, it's difficult to gauge the overall impact.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide investors with insights into the actions of company insiders, such as directors and officers.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates